Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation
This report summarises the results from two epidemiological studies conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium undertaken in eight European Union (EU)/European Economic Area (EEA) countries in order to investigate a possible association between an unexpected increase in narcolepsy cases following the use of influenza A(H1N1)pdm09 vaccines. Narcolepsy is an underdiagnosed disease of widely unknown etiology.
Public health guidance: Seasonal influenza vaccination of children and pregnant women
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.
Risk assessment: Seasonal influenza 2012/13 in Europe (EU/EEA countries)
ECDC has produced an annual risk assessment of the seasonal influenza epidemics in Europe since the 2010/11 season following the model developed by ECDC during the 2009 pandemic. It gives an early description of the influenza season in the countries affected earliest, providing guidance and information to countries that are affected later, as influenza progresses across Europe over several months. It describes any specifics of the season, particularly in areas where public health or clinical actions are envisaged, as well as highlights areas of uncertainty where further work is required.
Communicable disease threats report, 14-18 October 2013, week 42
The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control.
Review of the scientific literature on drivers and barriers of seasonal influenza vaccination coverage in the EU/EEA
The report aims to provide a critical review of evidence on the barriers and drivers of seasonal influenza vaccination coverage in the EU/EEA. The report focuses on high-risk groups where high coverage of seasonal flu vaccination is most important. The 2009 Council of the European Union Recommendation on seasonal influenza vaccination encourages countries to implement measures that would increase seasonal influenza vaccination uptake to at least 75% for defined older age groups, and, if possible, for other risk groups. In support of this, the ECDC report summarises the evidence on what are the barriers and what are the drivers for seasonal influenza vaccination by each risk group
Communicable disease threats report, 3-9 November 2013, week 45
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 November 2013, and includes updates on botulism, cholera, influenza, seasonal influenza, MERS, pertussis, polio and West Nile fever.
Communicable disease threats report, 8-14 December 2013, week 50
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 December 2013, and includes updates on chikungunya, dengue, influenza, seasonal influenza, MERS and polio.
Communicable disease threats report, 21-28 December 2013, week 52
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21-28 December 2013, and includes updates on chikungunya, seasonal influenza and MERS.
Implementation of the Council Recommendation on seasonal influenza vaccination
In support of the EU Council Recommendation of December 2009 on seasonal influenza vaccination, this technical report provides data on vaccination policies and strategies, vaccination coverage data, and data on barriers to vaccination for seasonal influenza in the EU/EEA countries.
Seasonal influenza - Annual Epidemiological Report for 2013-14 season
The 2013–14 influenza season was mild and dominated by influenza A viruses, with a co-circulation of A(H1N1)pdm09 and A(H3N2) viruses in most countries. Only two countries reported higher syndromic notification rates compared with the previous season.